Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placental Matrix-Derived MSCs for Erectile Dysfunction
NCT02398370Phase 1Completed
- Start
- Jul 2013
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of placental matrix-derived mesenchymal stem cells in erectile dysfunction (ED). Primary endpoint: Peak Systolic Velocity at 12 months. Started Jul 2013; status: completed.
02
Drugs
placental matrix-derived mesenchymal stem cells
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02398370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02398370.